Disruptive technologies in cardiac surgery and interventional cardiology
Keywords:
Mitral valve Aortic valve Valve surgery Valve intervention
Abstract
The last several decades have witnessed a huge expansion of surgical and interventional treatment of cardiac disease. Axel Cappelen from Oslo, Norway was one of the first to operate on the heart, something that had until then, been considered foolish and without chance of success. (1). Cappelen dared to operate on the heart in spite of Billroth’s stark warning against such “unwise” attempts as he ligated a bleeding coronary artery caused by a stabbing injury. Most of the innovation in recent years has been within the interventional cardiology domain in contrast to the first 7 decades of the 20.century, when surgeons dominated. Cardiac surgeons have developed less invasive procedures, although the most common surgical incision is based on the time-honored and large median sternotomy incision. Many surgeons continue to prefer the concept of “Grosse Chirurgen, Grosse Schnitte” and have stayed away from minimization and continue to use direct vision, usually augmented by magnification glasses, median sternotomy and cardiopulmonary bypass (CPB). However new technology has made the need for CPB less important (2). In this article we will describe a selection of recently developed devices for cardiac intervention.
References
1. Soreide K, Soreide JA. Axel H. Cappelen, MD (1858-1919): first suture of a myocardial laceration from a cardiac stab wound. The Journal of trauma. 2006;60(3):653-4.
2. Mujanovic E, Nurkic M, Caluk J, Terzic I, Kabil E, Bergsland J. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery. Innovations. 2009;4:265-8.
3. Bergsland J, D'Ancona G, Karamanoukian H, Ricci M, Schmid S, Salerno TA. Technical tips and pitfalls in OPCAB surgery: the buffalo experience. Heart Surg Forum. 2000;3(3):189-93.
4. Bergsland J, Hasnain S, Lajos TZ, Salerno TA. Elimination of cardiopulmonary bypass: a prime goal in reoperative coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;14(1):59-62; discussion -3.
5. Ricci M, Karamanoukian HL, Salerno TA, Dancona G, Bergsland J. Role of coronary graft flow measurement during reoperations for early graft failure after off-pump coronary revascularization. J Card Surg. 1999;14(5):342-7.
6. Heger JJ, Wann LS, Weyman AE, Dillon JC, Feigenbaum H. Long-term changes in mitral valve area after successful mitral commissurotomy. Circulation. 1979;59(3):443-8.
7. Khan MN. The relief of mitral stenosis. An historic step in cardiac surgery. Tex Heart Inst J. 1996;23(4):258-65; discussion 65-6.
8. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
9. Jabbour RJ, Dick R, Walton AS. Aortic balloon valvuloplasty--review and case series. Heart Lung Circ. 2008;17 Suppl 4:S73-81.
10. Baldwin ACW, Tolis G, Jr. Tissue Valve Degeneration and Mechanical Valve Failure. Current treatment options in cardiovascular medicine. 2019;21(7):33.
11. Acar C, Vahanian A, Jebara VA, Fabiani JN, Deloche A, Acar J, et al. Mitral valve repair for anterior leaflet disruption after percutaneous mitral dilation. J Thorac Cardiovasc Surg. 1991;102(3):468-9.
12. Jouan J, Berrebi A, Chauvaud S, Menasche P, Carpentier A, Fabiani JN. Mitral valve reconstruction in Barlow disease: long-term echographic results and implications for surgical management. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S17-20.
13. el Asmar B, Perier P, Couetil JP, Carpentier A. Failures in reconstructive mitral valve surgery. Le Journal medical libanais The Lebanese medical journal. 1991;39(1):7-11.
14. Gruntzig A, Hirzel H, Goebel N, Gattiker R, Turina M, Myler R, et al. [Percutaneous transluminal dilatation of chronic coronary stenoses. First experiences]. Schweizerische medizinische Wochenschrift. 1978;108(44):1721-3.
15. Barton M, Gruntzig J, Husmann M, Rosch J. Balloon Angioplasty - The Legacy of Andreas Gruntzig, M.D. (1939-1985). Front Cardiovasc Med. 2014;1:15.
16. Silin VA, Sukhov VK. [Percutaneous endovascular catheter balloon dilatation of mitral and aortic valve stenosis]. Vestnik khirurgii imeni I I. 1990;144(4):8-12.
17. Di Mario C, Beatt KJ, de Feyter P, van den Brand M, Essed CE, Serruys PW. Percutaneous aortic balloon dilatation for calcific aortic stenosis in elderly patients: immediate haemodynamic results and short-term follow up. British heart journal. 1987;58(6):644-52.
18. Lombardo S, Rosenberg JS, Kim J, Erdene S, Sergelen O, Nellermoe J, et al. Cost and outcomes of open versus laparoscopic cholecystectomy in Mongolia. The Journal of surgical research. 2018;229:186-91.
19. Pfannmuller B, Seeburger J, Misfeld M, Borger MA, Garbade J, Mohr FW. Minimally invasive mitral valve repair for anterior leaflet prolapse. J Thorac Cardiovasc Surg. 2013;146(1):109-13.
20. Letac B, Cribier A, Berland J. [Percutaneous valvuloplasty using a balloon catheter in acquired mitral and aortic stenosis in adults]. Schweizerische medizinische Wochenschrift. 1988;118(46):1673-80.
21. Cribier A. [Catheter-assisted implantation of aortic valves in degenerative aortic stenosis]. Bull Acad Natl Med. 2012;196(3):659-61.
22. Nombela-Franco L, Ruel M, Radhakrishnan S, Webb JG, Hansen M, Labinaz M, et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026-33.
23. Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Circ Cardiovasc Interv. 2016;9(6).
24. Reid CL, Rahimtoola SH. The role of echocardiography/Doppler in catheter balloon treatment of adults with aortic and mitral stenosis. Circulation. 1991;84(3 Suppl):I240-9.
25. Bergsland J, Elle OJ, Fosse E. Barriers to medical device innovation. Med Devices (Auckl). 2014;7:205-9.
26. Sideris K, Boehm J, Voss B, Guenther T, Lange RS, Guenzinger R. Functional and Degenerative Mitral Regurgitation: One Ring Fits All? Thorac Cardiovasc Surg. 2019.
27. Maisano F, Torracca L, Oppizzi M, Stefano PL, D'Addario G, La Canna G, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13(3):240-5; discussion 5-6.
28. Maisano F, Buzzatti N, Taramasso M, Alfieri O. Mitral transcatheter technologies. Rambam Maimonides Med J. 2013;4(3):e0015.
29. Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, et al. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. Am Heart J. 2018;205:1-11.
30. Ferrero Guadagnoli A, De Carlo C, Maisano F, Ho E, Saccocci M, Cuevas O, et al. Cardioband system as a treatment for functional mitral regurgitation. Expert review of medical devices. 2018;15(6):415-21.
31. Colli A, Adams D, Fiocco A, Pradegan N, Longinotti L, Nadali M, et al. Transapical NeoChord mitral valve repair. Annals of cardiothoracic surgery. 2018;7(6):812-20.
32. Colli A, Manzan E, Aidietis A, Rucinskas K, Bizzotto E, Besola L, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018;54(3):460-6.
33. Bergsland J, Mirtaheri P, Hiorth N, Fosse E. Review of the endovascular approach to mitral valve disease. Minim Invasive Ther Allied Technol. 2015;24(5):282-8.
34. Dahle G, Rein KA, Fiane AE. Single centre experience with transapical transcatheter mitral valve implantation. Interactive cardiovascular and thoracic surgery. 2017;25(2):177-84.
35. Niikura H, Gossl M, Sorajja P. Transcatheter Mitral Valve Replacement with Tendyne. Interv Cardiol Clin. 2019;8(3):295-300.
36. Quarto C, Davies S, Duncan A, Lindsay A, Lutter G, Lozonschi L, et al. Transcatheter Mitral Valve Implantation: 30-day Outcome of First-in-Man Experience With an Apically Tethered Device. Innovations (Phila). 2016;11(3):174-8.
37. Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, et al. Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement. Circ Cardiovasc Interv. 2018;11(10):e006412.
38. McCarthy PM, Kislitsina ON, Malaisrie SC, Davidson CJ. Transcatheter Mitral Valve Replacement with Intrepid. Interv Cardiol Clin. 2019;8(3):287-94.
39. Lanjewar C, Phadke M, Singh A, Sabnis G, Jare M, Kerkar P. Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults. Indian Heart J. 2017;69(2):176-81.
40. Markham R, Challa A, Kyranis S, Nicolae M, Murdoch D, Savage M, et al. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience. Heart Lung Circ. 2017;26(10):1085-93.
41. Cao JY, Wales KM, Zhao DF, Seco M, Celermajer DS, Bannon PG. Repair of Less Than Severe Tricuspid Regurgitation during Left Sided Valve Surgery: A Meta-Analysis. Ann Thorac Surg. 2019.
42. Karam N, Braun D, Mehr M, Orban M, Stocker TJ, Deseive S, et al. Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function. JACC Cardiovasc Interv. 2019;12(15):1413-20.
43. Williams AM, Bolling SF, Latib A. The five Ws of transcatheter tricuspid valve repair: Who, What, When, Where, and Why. EuroIntervention. 2019;15(10):841-5.
44. Kaplan AV, Williams DO. Medical device regulatory landscape: the imperative of finding balance. Circ Cardiovasc Interv. 2012;5(1):2-5.
2. Mujanovic E, Nurkic M, Caluk J, Terzic I, Kabil E, Bergsland J. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery. Innovations. 2009;4:265-8.
3. Bergsland J, D'Ancona G, Karamanoukian H, Ricci M, Schmid S, Salerno TA. Technical tips and pitfalls in OPCAB surgery: the buffalo experience. Heart Surg Forum. 2000;3(3):189-93.
4. Bergsland J, Hasnain S, Lajos TZ, Salerno TA. Elimination of cardiopulmonary bypass: a prime goal in reoperative coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;14(1):59-62; discussion -3.
5. Ricci M, Karamanoukian HL, Salerno TA, Dancona G, Bergsland J. Role of coronary graft flow measurement during reoperations for early graft failure after off-pump coronary revascularization. J Card Surg. 1999;14(5):342-7.
6. Heger JJ, Wann LS, Weyman AE, Dillon JC, Feigenbaum H. Long-term changes in mitral valve area after successful mitral commissurotomy. Circulation. 1979;59(3):443-8.
7. Khan MN. The relief of mitral stenosis. An historic step in cardiac surgery. Tex Heart Inst J. 1996;23(4):258-65; discussion 65-6.
8. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
9. Jabbour RJ, Dick R, Walton AS. Aortic balloon valvuloplasty--review and case series. Heart Lung Circ. 2008;17 Suppl 4:S73-81.
10. Baldwin ACW, Tolis G, Jr. Tissue Valve Degeneration and Mechanical Valve Failure. Current treatment options in cardiovascular medicine. 2019;21(7):33.
11. Acar C, Vahanian A, Jebara VA, Fabiani JN, Deloche A, Acar J, et al. Mitral valve repair for anterior leaflet disruption after percutaneous mitral dilation. J Thorac Cardiovasc Surg. 1991;102(3):468-9.
12. Jouan J, Berrebi A, Chauvaud S, Menasche P, Carpentier A, Fabiani JN. Mitral valve reconstruction in Barlow disease: long-term echographic results and implications for surgical management. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S17-20.
13. el Asmar B, Perier P, Couetil JP, Carpentier A. Failures in reconstructive mitral valve surgery. Le Journal medical libanais The Lebanese medical journal. 1991;39(1):7-11.
14. Gruntzig A, Hirzel H, Goebel N, Gattiker R, Turina M, Myler R, et al. [Percutaneous transluminal dilatation of chronic coronary stenoses. First experiences]. Schweizerische medizinische Wochenschrift. 1978;108(44):1721-3.
15. Barton M, Gruntzig J, Husmann M, Rosch J. Balloon Angioplasty - The Legacy of Andreas Gruntzig, M.D. (1939-1985). Front Cardiovasc Med. 2014;1:15.
16. Silin VA, Sukhov VK. [Percutaneous endovascular catheter balloon dilatation of mitral and aortic valve stenosis]. Vestnik khirurgii imeni I I. 1990;144(4):8-12.
17. Di Mario C, Beatt KJ, de Feyter P, van den Brand M, Essed CE, Serruys PW. Percutaneous aortic balloon dilatation for calcific aortic stenosis in elderly patients: immediate haemodynamic results and short-term follow up. British heart journal. 1987;58(6):644-52.
18. Lombardo S, Rosenberg JS, Kim J, Erdene S, Sergelen O, Nellermoe J, et al. Cost and outcomes of open versus laparoscopic cholecystectomy in Mongolia. The Journal of surgical research. 2018;229:186-91.
19. Pfannmuller B, Seeburger J, Misfeld M, Borger MA, Garbade J, Mohr FW. Minimally invasive mitral valve repair for anterior leaflet prolapse. J Thorac Cardiovasc Surg. 2013;146(1):109-13.
20. Letac B, Cribier A, Berland J. [Percutaneous valvuloplasty using a balloon catheter in acquired mitral and aortic stenosis in adults]. Schweizerische medizinische Wochenschrift. 1988;118(46):1673-80.
21. Cribier A. [Catheter-assisted implantation of aortic valves in degenerative aortic stenosis]. Bull Acad Natl Med. 2012;196(3):659-61.
22. Nombela-Franco L, Ruel M, Radhakrishnan S, Webb JG, Hansen M, Labinaz M, et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026-33.
23. Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Circ Cardiovasc Interv. 2016;9(6).
24. Reid CL, Rahimtoola SH. The role of echocardiography/Doppler in catheter balloon treatment of adults with aortic and mitral stenosis. Circulation. 1991;84(3 Suppl):I240-9.
25. Bergsland J, Elle OJ, Fosse E. Barriers to medical device innovation. Med Devices (Auckl). 2014;7:205-9.
26. Sideris K, Boehm J, Voss B, Guenther T, Lange RS, Guenzinger R. Functional and Degenerative Mitral Regurgitation: One Ring Fits All? Thorac Cardiovasc Surg. 2019.
27. Maisano F, Torracca L, Oppizzi M, Stefano PL, D'Addario G, La Canna G, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13(3):240-5; discussion 5-6.
28. Maisano F, Buzzatti N, Taramasso M, Alfieri O. Mitral transcatheter technologies. Rambam Maimonides Med J. 2013;4(3):e0015.
29. Mack MJ, Abraham WT, Lindenfeld J, Bolling SF, Feldman TE, Grayburn PA, et al. Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial. Am Heart J. 2018;205:1-11.
30. Ferrero Guadagnoli A, De Carlo C, Maisano F, Ho E, Saccocci M, Cuevas O, et al. Cardioband system as a treatment for functional mitral regurgitation. Expert review of medical devices. 2018;15(6):415-21.
31. Colli A, Adams D, Fiocco A, Pradegan N, Longinotti L, Nadali M, et al. Transapical NeoChord mitral valve repair. Annals of cardiothoracic surgery. 2018;7(6):812-20.
32. Colli A, Manzan E, Aidietis A, Rucinskas K, Bizzotto E, Besola L, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg. 2018;54(3):460-6.
33. Bergsland J, Mirtaheri P, Hiorth N, Fosse E. Review of the endovascular approach to mitral valve disease. Minim Invasive Ther Allied Technol. 2015;24(5):282-8.
34. Dahle G, Rein KA, Fiane AE. Single centre experience with transapical transcatheter mitral valve implantation. Interactive cardiovascular and thoracic surgery. 2017;25(2):177-84.
35. Niikura H, Gossl M, Sorajja P. Transcatheter Mitral Valve Replacement with Tendyne. Interv Cardiol Clin. 2019;8(3):295-300.
36. Quarto C, Davies S, Duncan A, Lindsay A, Lutter G, Lozonschi L, et al. Transcatheter Mitral Valve Implantation: 30-day Outcome of First-in-Man Experience With an Apically Tethered Device. Innovations (Phila). 2016;11(3):174-8.
37. Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, et al. Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement. Circ Cardiovasc Interv. 2018;11(10):e006412.
38. McCarthy PM, Kislitsina ON, Malaisrie SC, Davidson CJ. Transcatheter Mitral Valve Replacement with Intrepid. Interv Cardiol Clin. 2019;8(3):287-94.
39. Lanjewar C, Phadke M, Singh A, Sabnis G, Jare M, Kerkar P. Percutaneous balloon valvuloplasty with Inoue balloon catheter technique for pulmonary valve stenosis in adolescents and adults. Indian Heart J. 2017;69(2):176-81.
40. Markham R, Challa A, Kyranis S, Nicolae M, Murdoch D, Savage M, et al. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience. Heart Lung Circ. 2017;26(10):1085-93.
41. Cao JY, Wales KM, Zhao DF, Seco M, Celermajer DS, Bannon PG. Repair of Less Than Severe Tricuspid Regurgitation during Left Sided Valve Surgery: A Meta-Analysis. Ann Thorac Surg. 2019.
42. Karam N, Braun D, Mehr M, Orban M, Stocker TJ, Deseive S, et al. Impact of Transcatheter Tricuspid Valve Repair for Severe Tricuspid Regurgitation on Kidney and Liver Function. JACC Cardiovasc Interv. 2019;12(15):1413-20.
43. Williams AM, Bolling SF, Latib A. The five Ws of transcatheter tricuspid valve repair: Who, What, When, Where, and Why. EuroIntervention. 2019;15(10):841-5.
44. Kaplan AV, Williams DO. Medical device regulatory landscape: the imperative of finding balance. Circ Cardiovasc Interv. 2012;5(1):2-5.
Published
2020/03/27
Issue
Section
Current topic
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).